dexmedetomidine + magnesium sulphate

Dexmedetomidine + magnesium sulphate is a combination of two agents used primarily as adjuncts in anesthesia and critical care settings. Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist that provides sedation, anxiolysis, and analgesia without significant respiratory depression. Magnesium sulphate acts as an NMDA receptor antagonist, calcium channel blocker, and central nervous system depressant with anticonvulsant properties. The combination has been studied for its synergistic effects in several clinical scenarios: - In alcohol withdrawal delirium (delirium tremens), the combination shortens the duration of delirium more effectively than either agent alone or standard therapy, improves hemodynamic stability (mean arterial pressure and heart rate), normalizes plasma cortisol and serotonin levels (biomarkers of stress response), does not adversely affect kidney or liver function, and reduces complications such as hypotension or bradycardia compared to monotherapy[1][5][2]. - As adjuvants to local anesthetics (e.g., levobupivacaine) for regional blocks such as spermatic cord block during testicular surgery, the combination prolongs postoperative analgesia duration more than either agent alone[3]. - Both drugs are also individually used for controlled hypotension during surgery to improve surgical field quality[9]. The mechanism involves combined alpha-2 adrenergic agonism by dexmedetomidine (reducing sympathetic outflow) with NMDA antagonism/calcium channel blockade by magnesium sulphate (dampening neuronal excitability). This results in enhanced sedation/analgesia with improved safety profile.

Brand names

Precedex

Other names

dexmedetomidine and magnesium sulfatedexmedetomidine and magnesium sulphate